Collateralized Fund Obligations: How Wall Street Is Securitizing Private Markets
TL;DR: A Collateralized Fund Obligation (CFO) is a securitization backed by a pool of private fund LP stakes, not individual loans. Churchill Asset Management and Seviora closed a $400 million CFO in

On July 22, 2026, Churchill Asset Management and Singapore-based Seviora closed a $400 million Collateralized Fund Obligation, the first structure of its kind to combine US junior capital with Asian private capital strategies inside a single securitization vehicle. The deal was oversubscribed. US insurance companies took the bulk of the senior notes. That sequence tells you everything about who captures value first.
The Churchill-Seviora Deal: What Actually Happened
Churchill Asset Management is a subsidiary of Nuveen Private Capital, which operates inside TIAA's $99 billion private capital platform. Seviora is Temasek's asset management arm, running $75 billion in AUM out of Singapore. These are not emerging managers testing a novel idea. They are incumbents with deep LP relationships and decades of institutional infrastructure.
The $400 million CFO allocates 50% to US junior capital (subordinated private credit) and 50% to Asian private capital strategies, primarily private equity and credit funds across Southeast Asia and adjacent markets. That geographic split is the structural novelty. Most prior CFOs drew from a single regional LP book. This one spans two continents, two regulatory environments, and two distinct vintage-year cycles.
The deal was oversubscribed before it closed. US insurance companies bought the senior notes in volume. Insurers need AAA- or AA-rated fixed income that matches their liability duration and satisfies capital requirements under Solvency and RBC frameworks. A CFO senior tranche delivers a yield pickup over comparably rated corporate bonds, which is precisely why insurer demand outstripped supply before the deal priced.
Ares Management and Carlyle's AlpInvest have issued CFOs in recent years. The Churchill-Seviora transaction accelerates the pace and broadens the geographic scope of the market as dealmaking slows and GPs seek liquidity solutions.
What a CFO Actually Is (and How It Differs from a CLO)
A Collateralized Fund Obligation (CFO) is a securitization backed by a diversified portfolio of private fund interests, specifically LP stakes in private equity or private credit funds. A special purpose vehicle acquires those LP interests, pools them, and issues tranched debt and equity against the expected cash flows from underlying fund distributions.
A Collateralized Loan Obligation (CLO) holds individual corporate loans, typically 150 to 300 floating-rate leveraged loans made directly to borrowing companies. A CFO holds interests in funds that themselves hold those loans or equity positions. CFO investors sit one layer further from the underlying assets than CLO investors do. That additional layer matters for transparency and for cash flow predictability.
CLO cash flows arrive on schedule: loan interest payments land quarterly, defaults follow actuarial patterns, and the waterfall mechanics are well-tested across 30-plus years of market history. CFO cash flows depend on when underlying GPs decide to distribute capital. That decision depends on exits, which depend on M&A markets, IPO windows, and GP incentive structures that have nothing to do with your note payment schedule. GPs do not distribute capital on a timeline that optimizes your debt service.
That structural mismatch sits at the heart of every CFO. The liability side (debt tranches) demands predictable cash flows. The asset side (LP stakes in closed-end funds) delivers cash when GPs choose to sell. Reserve accounts, coverage tests, and the equity cushion manage that mismatch, but they do not eliminate it.
How CFO Tranches Work
A CFO issues multiple security classes from a single SPV. Senior notes rated AAA or AA sit at the top of the payment waterfall and collect principal and interest before any junior class receives a dollar. Mezzanine notes occupy the middle tier, carrying higher yield in exchange for absorbing losses before the senior class is touched. The equity tranche, sometimes called the residual or first-loss piece, sits at the bottom and captures the upside in favorable exit environments.
Insurance companies buy senior CFO tranches because the high rating satisfies regulatory capital requirements while the yield exceeds comparably rated investment-grade corporate bonds by 50 to 150 basis points, depending on deal structure and underlying fund vintage. The equity tranche can target 15% to 20% net IRR in favorable exit environments. It can also be wiped out when distributions stall.
Coverage tests run continuously. When the ratio of asset value to senior debt falls below a defined threshold, the waterfall diverts cash away from junior and equity holders to pay down senior notes first. Equity holders stop receiving distributions until the structure repairs itself. This outcome is not theoretical. It played out in multiple CLOs during 2020 and the same mechanics would trigger in CFOs under equivalent stress.
Who Buys CFOs and Why
The buyer base is almost entirely institutional. Life insurance companies dominate the senior note market. Their regulatory capital frameworks assign lower capital charges to highly rated fixed income, so a AA-rated CFO note with a 250-basis-point spread over Treasuries is genuinely attractive compared to a corporate bond at 150 basis points. The spread compensates for illiquidity and structural complexity, not necessarily for higher default risk at the senior level.
Pension funds, sovereign wealth funds, and endowments sometimes take mezzanine exposure. Family offices and sophisticated accredited investors occasionally access the equity tranche through fund-of-funds structures or secondary market purchases, though direct equity access outside of GP relationships is uncommon.
Retail accredited investors with $1 million net worth almost never see the primary market. By the time a CFO reaches retail distribution channels, the senior economics have already been captured by insurers, and the remaining access points carry additional fee layers.
Why GPs Use CFOs
Here is the honest answer. GPs build CFOs because dealmaking slowed and LP distributions dried up. When exit markets close, when M&A volume drops and IPO windows shut, GPs cannot return capital to LPs on schedule. LPs grow impatient. New fundraising gets harder. A CFO lets the GP monetize a slice of the portfolio now, without selling underlying assets, by pledging LP stakes as collateral for a debt issuance.
The GP receives liquidity. The insurer gets yield. The equity investor in the CFO gets upside exposure if exits eventually materialize. The original LP in the underlying fund is still waiting. Their fund interests have been pledged inside an SPV, and they hold no direct claim on that SPV's proceeds. They remain in the same distribution queue they were always in, with a new layer of financial engineering sitting above them.
That is not fraud. It is a legal structure explicitly permitted under most fund partnership agreements. But accredited investors evaluating CFOs need to understand the incentive alignment clearly: the GP has already extracted liquidity. The LP has not.
The market is growing because the underlying problem, slow distributions in a high-rate environment, is not going away. Private credit fund managers and private equity GPs face identical distribution pressure, which means CFO issuance will accelerate through 2026 and into 2027 regardless of where interest rates land.
The Risks for Accredited Investors
The structural risks in a CFO are real and specific. Know them before you invest.
Cash flow timing risk. Underlying LP stakes distribute capital when GPs exit positions. If exit markets stay closed, as they did from mid-2022 through 2024, cash flows slow. Coverage tests tighten. Junior tranches stop receiving distributions. Equity tranches get zeroed temporarily or permanently.
Valuation opacity. Private fund NAVs are marked quarterly by GPs using models, not market prices. The collateral pool inside a CFO is valued based on those GP marks. If the marks are optimistic (and there is significant evidence from 2022 to 2024 that many were), coverage ratios appear healthier than they are until a realization event forces a markdown. Fitch Ratings caps its PE CFO ratings at the 'Asf' category specifically because the asset class lacks the track record to support higher confidence in projected cash flows under stress scenarios.
Illiquidity. CFO tranches are not exchange-traded. Secondary market trading exists but is thin. If you need to exit before maturity, expect a discount of 5% to 20% depending on market conditions. Senior notes trade tighter than mezzanine. Equity tranches may find no bid at all in a risk-off environment.
Fee drag. A CFO stacks fees on top of already fee-heavy private fund structures. Underlying funds charge management fees and carried interest. The CFO SPV charges management and structuring fees. Placement agents charge distribution fees. By the time cash flows through all those layers to a mezzanine or equity investor, net returns compress significantly.
Correlation risk. The Churchill-Seviora deal promotes geographic diversification, 50% US and 50% Asian strategies. Diversification is real but imperfect. In a global risk-off event like 2008 or March 2020, private asset values across geographies moved together. Correlation that looks low in normal markets spikes in crises, exactly when you need diversification most.
For accredited investors comparing alternatives, private equity secondary funds offer similar diversification benefits with more direct control over vintage and asset selection.
How to Evaluate or Access CFOs
Most accredited investors cannot access CFO primary issuance directly. Minimum investments for institutional tranches run from $1 million to $10 million per note class, and placement runs through private bank channels or direct insurer relationships. Equity tranches are typically retained by the GP or placed with a small group of anchor investors before the deal closes.
Secondary market access is available through specialty brokers that run LP stake and CFO note trading: Setter Capital, Greenhill's private capital advisory, and Lazard's alternative asset group are active in this space. Prices depend on underlying fund vintage, NAV marks, and the remaining distribution timeline.
Before committing to any CFO exposure, direct or through a fund-of-funds wrapper, ask four specific questions. First: what is the weighted average age of the underlying LP stakes, and how many are within three years of their expected distribution window? Second: what coverage ratio triggers diversion of cash flows to senior note repayment, and how close is the current portfolio to that threshold? Third: what is the total fee load across all layers, expressed as an equivalent annual drag on gross IRR? Fourth: who retains the equity tranche, and does their retention align their incentives with yours or with the GP's liquidity needs?
The Churchill-Seviora CFO is a sophisticated structure built by two credible institutions with real track records. It is not a red flag. But it is a product designed first to solve the GP's liquidity problem and second to deliver returns to investors. Knowing which comes first is the starting point for any honest due diligence.
For more context on how CFOs fit inside a broader allocation, see our guides on structured credit investing for accredited investors and private markets portfolio construction.
Frequently Asked Questions
- What is the difference between a CFO and a CLO?
- A CLO holds individual corporate loans directly, typically 150 to 300 floating-rate leveraged loans. A CFO holds LP interests in private equity or private credit funds. CLO investors are one layer from the underlying borrower. CFO investors are two layers removed. That extra layer adds complexity, reduces transparency, and creates cash flow timing dependency on GP exit decisions rather than loan amortization schedules.
- Why did US insurance companies buy the Churchill-Seviora CFO senior notes?
- Insurance companies need highly rated fixed income that matches their liability duration and satisfies regulatory capital requirements. A AAA- or AA-rated CFO senior note offers 50 to 150 basis points more yield than a comparably rated corporate bond. That spread compensates for illiquidity and structural complexity, both of which insurers can absorb given their long-duration liability books. The Churchill-Seviora deal was oversubscribed because insurer demand for structured credit with this risk-return profile exceeded supply.
- What rating does Fitch assign to private equity CFOs?
- Fitch caps its PE CFO ratings at the 'Asf' category under its current rating criteria. The cap reflects the limited performance history of CFOs as an asset class, the opacity of private fund NAV marks, and the unpredictable timing of LP distributions. An 'Asf' cap does not mean every tranche earns that rating. It means no tranche in a PE CFO can exceed that ceiling regardless of structural enhancements.
- Can accredited investors access CFOs directly?
- Rarely through primary issuance. Institutional minimums of $1 million to $10 million per tranche and private placement distribution channels shut out most individual accredited investors. Secondary market access runs through specialty brokers including Setter Capital, but liquidity is thin and pricing is opaque. Fund-of-funds vehicles that include CFO exposure are the most accessible entry point for individuals, though each additional wrapper adds another fee layer that compresses net returns.
class="disclosure">Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.
Part of Guide
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
About the Author
Jeff Barnes, MBA
Continue Reading

GTCR's $1.25B Capital Solutions Fund: Why Minority Structured Equity Is Having a Moment

Eagle Point's $14B Private Credit Bet on U.S. Battery Manufacturing

Hard Money Lending: The High-Yield Real Estate Debt Strategy for Accredited Investors

Private Credit in 2026: The $1.7 Trillion Market Accredited Investors Can Now Access

Upstart and Castlelake's $4B Forward-Flow Deal: What Private Credit's AI Bet Means for Accredited Investors
